Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-24 @ 5:53 PM
NCT ID:
NCT01442168
Eligibility Criteria:
Inclusion Criteria:
* Presence of acute uncomplicated P. falciparum malaria, confirmed by positive blood smear with asexual forms of a single species (P. falciparum)
* Counts of asexual forms of P. falciparum: 10 000- 100 000/ul with or without gametocytaemia
* Presence of fever defined as \> 38°C tympanic temperature or a history of fever within the last 24 hours
Exclusion Criteria:
* Mixed infection with other Plasmodium species
* Any criteria of severe or complicated malaria as defined by the WHO, 2010
* Use of high doses aspirin (more than 100 mg/day) or dual anti-platelet therapy or use of heparin,Low Molecular Weight Heparin (LMWH) or warfarin
* Presence of significant anemia as defined by Hb \<8 g/dL or Hct \< 25%
* A platelet count \< 50,000/μL
* Presence of febrile conditions caused by diseases other than malaria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01442168
Study Brief:
Protocol Section:
NCT01442168